Cardiomyopathy News and Research

RSS

Cardiomyopathy is a group of diseases with primary, usually diffuse, involvement of the myocardium. The myocardial disease is not secondary to ischaemic, valvular, congenital or pericardial disease.

Novel insights into pathologies of diabetic cardiomyopathy, hippocampal neurotoxicity, and Alzheimer’s

DCM is the leading cause of heart failure in patients with chronic diabetes. However, the underlying mechanisms of DCM are poorly understood, and treatment options are limited.

26 Feb 2024

Harvard study links PM2.5 air pollution to increased risk of cardiovascular hospitalization in seniors

Chronic exposure to fine particulate air pollutants (PM2.5) may increase seniors' risk of hospitalization for a variety of cardiovascular conditions, according to a new study led by Harvard T.H. Chan School of Public Health.

22 Feb 2024

Major study of 59 million Americans finds fine particulate matter from air pollution increases heart disease risks

Relationships between air pollution and the probability of first-time hospitalization for CVD.

22 Feb 2024

Fine particulate matter exposure linked to increased hospital admissions for major diseases

Short and long term exposure to fine particulate matter (PM2.5) air pollution is linked to an increased risk of hospital admission for major heart and lung diseases, find two large US studies, published by The BMJ today.

21 Feb 2024

Sleep apnea prevalent among cardio-oncology patients, study shows

Sleep apnea is prevalent among cardio-oncology patients who are at higher risk for congestive heart failure from cancer therapy, according to a new study being presented at the American College of Cardiology (ACC) Advancing the Cardiovascular Care of the Oncology Patient course.

9 Feb 2024

Gene therapy could prolong survival in some people with arrhythmogenic right ventricular cardiomyopathy

A new study in mice shows that replacement of a dysfunctional gene could prolong survival in some people with arrhythmogenic right ventricular cardiomyopathy (ARVC), a rare inherited disorder in which the muscular walls of the heart progressively weaken and put patients at risk of dangerous irregular heartbeats.

30 Jan 2024

Mayo Clinic unveils "secret gene" key to reversing heart failure in some patients

Mayo Clinic researchers studying the genetics of people who had recently developed dilated cardiomyopathy, one of the most common causes of heart failure, have found a particular gene to target for developing future drug therapy treatments.

24 Jan 2024

Behavioral activation vs antidepressants: Which wins for heart failure patients with depression?

The efficacy of antidepressant medication management (MEDS) against behavioral activation psychotherapy (BA).

17 Jan 2024

Phase 3 trial shows acoramidis safe and effective for transthyretin amyloid cardiomyopathy

Pumping over 100,000 times a day, the heart is a critical muscle needed to deliver oxygen and nutrients to our organs to sustain healthy bodily function.

16 Jan 2024

Scotland's NHS Golden Jubilee heart transplant unit expands to support more patients

Scotland’s only heart transplant centre at NHS Golden Jubilee, is expanding to support more patients across Scotland than ever before.

13 Jan 2024

Simple biomarkers offer early warning of hidden heart risk in childhood cancer survivors

Data from the St. Jude lifetime cohort study (St. Jude LIFE) revealed that two common biomarkers of cardiac function and damage could better predict cardiomyopathy within five years than routine clinical evaluations in high-risk, asymptomatic childhood cancer survivors.

11 Jan 2024

Groundbreaking drug offers new hope for life-threatening heart condition

People diagnosed with a life-threatening cardiac condition have been given new hope, thanks to a ground-breaking new drug that protects the heart developed by researchers from UCL and the Royal Free Hospital.

11 Jan 2024

Small declines in blood lead levels linked to long-term cardiovascular health improvements

Through the Strong Heart Family Study, National Institutes of Health-supported researchers found that small declines in blood lead levels were associated with long-term cardiovascular health improvements in American Indian adults.

11 Jan 2024

AI-enabled digital stethoscope could improve the diagnosis of peripartum cardiomyopathy

New research from Mayo Clinic suggests that artificial intelligence (AI) could improve the diagnosis of peripartum cardiomyopathy, a potentially life-threatening and treatable condition that weakens the heart muscle of women during pregnancy or in the months after giving birth.

8 Jan 2024

Researchers harness the power of AI to enhance assessment of the heart's right ventricle

In a milestone study, researchers from the Icahn School of Medicine at Mount Sinai have harnessed the power of artificial intelligence (AI) to enhance the assessment of the heart's right ventricle, which sends blood to the lungs.

4 Jan 2024

Existing beta blocker investigated as novel sickle cell therapy

A beta blocker typically used to treat heart problems, hemangioma, migraines and anxiety could be a new therapeutic for patients with sickle cell disease. Researchers led by Ankit A. Desai, MD, associate professor of medicine at the Krannert Cardiovascular Research Center (KCVRC) at Indiana University School of Medicine, have been awarded a $3 million grant by the U.S. Department of Defense to evaluate the efficacy of this drug.

3 Jan 2024

Cardiomyopathy News and Research

Further Reading

Novel insights into pathologies of diabetic cardiomyopathy, hippocampal neurotoxicity, and Alzheimer’s

Harvard study links PM2.5 air pollution to increased risk of cardiovascular hospitalization in seniors

Major study of 59 million Americans finds fine particulate matter from air pollution increases heart disease risks

Fine particulate matter exposure linked to increased hospital admissions for major diseases

Sleep apnea prevalent among cardio-oncology patients, study shows

Gene therapy could prolong survival in some people with arrhythmogenic right ventricular cardiomyopathy

Mayo Clinic unveils "secret gene" key to reversing heart failure in some patients

Behavioral activation vs antidepressants: Which wins for heart failure patients with depression?

Phase 3 trial shows acoramidis safe and effective for transthyretin amyloid cardiomyopathy

Scotland's NHS Golden Jubilee heart transplant unit expands to support more patients

Simple biomarkers offer early warning of hidden heart risk in childhood cancer survivors

Groundbreaking drug offers new hope for life-threatening heart condition

Small declines in blood lead levels linked to long-term cardiovascular health improvements

AI-enabled digital stethoscope could improve the diagnosis of peripartum cardiomyopathy

Researchers harness the power of AI to enhance assessment of the heart's right ventricle

Existing beta blocker investigated as novel sickle cell therapy

Stem cell heart tissue model paves the way for better understanding of tachycardia

Genetic analysis highlights potential concerns for heart health in elite athletes

St. Jude study sheds light on prediabetes prevalence and diabetes risk in childhood cancer survivors

Gene therapy shows promise for arrhythmogenic cardiomyopathy

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News